Summary
Fibroblast growth factors (FGF) and type β-1 transforming growth factor (TGFβ1) are pleiotropic regulatory peptides which are expressed in myocardium in a precise developmental and spatial program and are up-regulated, in the adult heart, by ischemia or a hemodynamic burden. The accumulation of trophic factors after aortic banding supports the hypothesis that autocrine or paracrine pathways might function to mediate, in part, the consequences of mechanical load. Our laboratory has demonstrated that cardiac muscle cells are targets for the action of peptide growth factors and, more specifically, that modulation of the cardiac phenotype by basic FGF (bFGF) and TGFβ 1 strongly resembles the induction of fetal cardiac genes — including skeletal α-actin (SkA), β-myosin heavy chain, and atrial natriuretic factor — which are characteristic of pressure-overload hypertrophy. Unexpectedly, and despite effects like those of bFGF on five other cardiac genes, acidic FGF (aFGF) was found to repress, rather than stimulate, SkA transcription in neonatal cardiac muscle cells. The proximal 200 nucleotides of a heterologous SkA promoter were sufficient for basal tissue-specific transcription, for induction by bFGF, and for inhibition by aFGF. Thus, both positive and negative regulation by peptide growth factors can be localized to the proximal SkA promoter. Full promoter activity required each of three CC[A/T]6GG motifs similar to the serum response element (SRE) for activation of the c-fos proto-oncogene, as previously shown for SkA transcription in a skeletal muscle background. The most proximal SRE, SRE1, was sufficient in the absence of other SkA promoter sequences for efficient tissue-specific expression in cardiac myocytes (versus cardiac fibroblasts), and was stimulated by bFGF to the same extent as the full-length promoter and endogeneous gene. Despite its ability to repress the SkA promoter, aFGF had no significant effect on SRE1. Both FGFs up-regulated the canonical fos SRE, to a comparable degree. Thus, SRE1 can discriminate between signals generated in cardiac myocytes by bFGF and aFGF. In cardiac myocyte extracts, two predominant proteins contact SRE1: serum response factor (SRF) and a second protein, F-ACT-1. Thus, serum response factor and F-ACT-1 are candidate trans-acting factors for basal transcription of the SkA gene in cardiac muscle cells and for induction of SkA by bFGF and, potentially, other trophic signals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bergsma DJ, Grichnik JM, Gossett LM, Schwartz RJ (1986) Delimitation and characterization of cis-acting DNA sequences required for the regulated expression and transcriptional control of the chicken skeletal alpha-actin gene. Mol Cell Biol 6:2462–2475
Black FB, Packer SE, Parker TG, Michael LH, Roberts R, Schwartz RJ, Schneider MD (1991) The vascular smooth muscle α-actin gene is reactivated during cardiac hypertrophy produced by load. J Clin Invest 88:1581–1588
Boxer LM, Prywes R, Roeder RG, Kedes L (1989) The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factor. Mol Cell Biol 9:515–522
Brennan TJ, Edmondson DG, Li L, Olson EN (1991) Transforming growth factor-beta represses the actions of myogenin through a mechanism independent of DNA binding. Proc Natl Acad Sci USA 88:3822–3826
Caffrey JM, Brown AM, Schneider MD (1987) Mitogens and transfected oncogenes can selectively block the expression of voltage-gated ion channels. Science 236:570–574
Chow KL, Hogan ME, Schwartz RJ (1991) Phased cis-acting promoter elements interact short distances to direct avian skeletal alpha-actin gene transcription. Proc Natl Acad Sci USA 88:1301–1305
Chow KL, Schwartz RJ (1990) A combination of closely associated positive and negative cis-acting promoter elements regulates transcription of the skeletal alpha-actin gene. Mol Cell Biol 10:528–538
Clegg CH, Linkhart TA, Olwin BB, Hauschka SD (1987) Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J Cell Biol 105:949–956
Englemann GL, Dionne CA, Jaye MC (1991) Acidic fibroblast growth factor heart development and capillary angiogenesis. In: Baird A, Klagsbrun M (eds) The Fibroblast Growth Factor Family. Ann NY Acad Sci 638:
Farnsworth CL, Marshall MS, Gibbs JB, Stacey DW, Feig LA (1991) Preferential inhibition of the oncogenic form of RasH by mutations in the GAP binding/“effector” domain. Cell 64:625–633
Gilman MZ, Wilson RN, Weinberg RA (1986) Multiple protein-binding sites in the 5’-flanking region regulate c-fos expression. Mol Cell Biol 6:4305–4316
Gius D, Cao XM, Rauscher FJ, Cohen DR, Curran T, Sukhatme VP (1990) Transcriptional activation and repression by fos are independent functions — The C-terminus represses immediate-early gene expression via CArG elements. Mol Cell Biol 10:4243–4255
Herrera RE, Shaw PE, Nordheim A (1989) Occupation of the c-fos serum response element in vivo by a multi-protein complex is unaltered by growth factor induction. Nature 340:68–70
Imamura T, Engleka K, Zhan X, Tokita Y, Forough R, Roeder D, Jackson A, Maier JAM, Hla T, Maciag T (1990) Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science 249:1567–1570
Izumo S, Lompre AM, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B, Mahdavi V (1987) Myosin heavy chain messenger RNA and protein isoform during cardiac hypertrophy: Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest 79:970–977
Izumo S, Nadal-Ginard B, Mahdavi V (1988) Proto-oncogene induction and repro-gramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85:339–343
Jamal S, Ziff E (1990) Transactivation of c-fos and β-actin genes by raf as a step in early response to transmembrane signals. Nature 344:463–466
Johnson DE, Lee PE, Lu J, Williams LT (1990) Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol Cell Biol 10:4728–4736
Kardami E, Fandrich RR (1989) Heparin-binding mitogen(s) in the heart; in search of origin and function. In: Kedes LH, Stockdale FE (eds) Cellular and Molecular Biology of Muscle Development. Alan R Liss Inc, New York, pp 315–325
Komuro I, Kaida T, Shibazaki Y, Kurabayashi M, Katoh Y, Hoh E, Takaku F, Yazaki Y (1990) Stretching cardiac myocytes stimulates protooncogene expression. J Biol Chem 265:3595–3598
Komuro I, Katoh Y, Kaida T, Shibazaki Y, Kurabayashi M, Hoh E, Takaku F, Yazaki Y (1991) Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. Possible role of protein kinase C activation. J Biol Chem 266:1265–1268
Komuro I, Kurabayashi M, Shibazaki Y, Takak F, Yazaki Y (1989) Molecular cloning and characterization of Ca2+ + Mg2+-dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum. J Clin Invest 83:1102–1108
Komuro M, Kurabayashi M, Takaku F, Yazaki Y (1988) Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overload hypertrophy of the rat heart. Circ Res 62:1075–1079
Konieczny SF, Drobes BL, Menke SL, Taparowsky EJ (1989) Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down-regulation of the MyoD1 gene. Oncogene 4:473–481
Lamb NIC, Fernandez A, Toukine N, Jeantuer P, Blanchard J-M (1990) Demonstration in living cells of an intragenic negative regulatory element within the rodent c-fos gene. Cell 61:485–496
Lassar AB, Thayer JM, Overell RW, Weintraub H (1989) Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell 58:659–667
Lee T-C, Chow K-L, Fang P, Schwartz RJ (1991) Activation of skeletal α-actin gene transcription: The cooperative formation of serum response factor binding complexes over positive cis-acting promoter SREs displaces a negative acting nuclear factor enriched in replicating myoblasts and nonmyogenic cells. Mol Cell Biol 11:5090–5100
Lucibello FC, Lowag C, Neuberg M, Müller R (1989) Trans-repression of the mouse c-fos promoter: A novel mechanism of fos-mediated trans-regulation. Cell 59:999–1007
Manak JR, Prywes R (1991) Mutation of serum response factor phosphorylation sites and the mechanism by which its DNA-binding activity is increased by casein kinase-II. Mol Cell Biol 11:3652–3659
Metz R, Ziff E (1991) cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription. Genes & Dev 5:1754–1766
Miki T, Fleming TP, Bottaro DP, Rubin JS, Ron D, Aaronson SA (1991) Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science 251:72–75
Miwa T, Kedes L (1987) Duplicated CArG box domains have positive and mutually regulatory roles in expression of the human alpha-cardiac actin. Mol Cell Biol 7:2803–2813
Mulvagh SL, Michael LH, Perryman MB, Roberts R, Schneider MD (1987) A hemodynamic load in vivo induces cardiac expression of the cellular oncogene, c-myc. Biochem Biophys Res Commun 147:627–636
Nadal-Ginard B, Mahdavi V (1989) Molecular basis of cardiac performance: Plasticity of the myocardium generated through protein isoform switches. J Clin Invest 84:1693–1700
Olson EN (1990) MyoD family: a paradigm for development? Genes Dev 4:1454–1461
Olson EN, Spizz G, Tainsky MA (1987) The oncogeneic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol Cell Biol 7:2104–2111
Olson EN, Sternberg E, Hu JS, Spizz G, Wilcox C (1986) Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol 103:1799–1805
Olwin BB, Hauschka SD (1990) Fibroblast growth factor receptor levels decrease during chick embryogenesis. J Cell Biol 110:503–509
Pari G. Jardine K, Mcburney MW (1991) Multiple CarG boxes in the human cardiac actin gene promoter required for expression in embryonic cardiac muscle cells developing in vitro from embryonal carcinoma cells. Mol Cell Biol 11:4796–4803
Parker TG, Chow K-L, Schwartz RJ, Schneider MD (1990) Differential regulation of skeletal α-actin transcription in cardiac muscle by two fibroblast growth factors. Proc Natl Acad Sci USA 87:7066–7070
Parker TG, Chow K-L, Schwartz RJ, Schneider MD (1992) Positive and negative control of the skeletal α-actin promoter in cardiac muscle: A proximal serum response element is sufficient for induction by basic FGF but not for inhibition by acidic FGF. J Biol Chem 267:3343–3350
Parker TG, Packer SE, Schneider MD (1990) Peptide growth factors can provoke “fetal” contractile protein gene expression in rat cardiac myocytes. J Clin Invest 85:507–514
Parker TG, Schneider MD (1991) Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype. Ann Rev Physiol 53:179–200
Parlow MH, Bolender DL, Kokan-Moore NP, Lough J (1991) Localization of bFGF-like proteins as punctate inclusions in the pre-septation myocardium of the chicken embryo. Dev Biol 146:139–147
Partanen J, Makela TP, Eerola E, Korhonen J, Hirvonen H, Claessonwelsh L, Alitalo K (1991) FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J 10:1347–1354
Payne PA, Olson EN, Hsiau P, Roberts R, Perryman MB, Schneider MD (1987) An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal. Proc Natl Acad Sci USA 84:8956–8960
Ransone LJ, Visvader J, Wamsley P, Verma IM (1990) Trans-dominant negative mutants of Fos and Jun Proc Natl Acad Sci USA 87:3806–3810
Riggs KJ, Merrell KT, Wilson G, Calame K (1991) Common factor 1 is a transcriptional activator which binds in the c-myc promoter, the skeletal α-actin promoter, and the immunoglobulin heavy-chain enhancer. Mol Cell Biol 11:1765–1769
Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J, Chein KR (1991) Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an invivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88:8277–8281
Ruzicka DL, Schwartz RJ (1988) Sequential activation of α-actin genes during avian cardiogenesis: vascular smooth muscle α-actin gene transcripts mark the onset of car-diomyocyte differentiation. J Cell Biol 107:2575–2586
Ryan WA Jr., Franza BR Jr., Gilman MZ (1989) Two distinct cellular phosphoproteins bind to the c-fos serum response element. EMBO J 8:1785–1792
Santoro IM, Walsh K (1991) Natural and synthetic DNA elements with the CArG motif differ in expression and protein-binding properties. Mol Cell Biol 11:6296–6305
Sartorelli V, Kedes L (1991) A MyoD binding site regulates the human cardiac alpha-actin gene promoter in primary cardiac cells. Circulation 84:11–531
Sartorelli V, Webster KA, Kedes L (1990) Muscle-specific expression of the cardiac alpha-actin gene requires MyoD1, CArG-box binding factor, and Spl. Genes & Dev 4:1811–1822
Schneider MD, Parker TG (1990) Cardiac myocytes as targets for peptide growth factors. Circulation 81:1443–1456
Schneider MD, Parker TG (1991) Cardiac growth factors. Prog Growth Factor Res 3:1–26
Schwartz K, de la Bastie D, Bouveret P, Oliviero P, Alonso S, Buckingham M (1986) α-Skeletal muscle actin mRNAs accumulate in hypertrophied adult rat hearts. Circ Res 59:551–555
Shaw PE, Schroter H, Nordheim A (1989) The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter. Cell 56:563–572
Sheng M, Dougan ST, McFadden G, Greenberg ME (1988) Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol Cell Biol 8:2787–2796
Shih HT, Wathen MS, Bigo-Marshall H, Caffrey JM, Schneider MD (1990) Dihydropyri-dine receptor gene expression is regulated by inhibitors of myogenic differentiation and is relatively insensitive to denervation. J Clin Invest 85:781–789
Stacey DW, Feig LA, B GJ (1991) Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras Mol Cell Biol 11:4053–4064
Swynghedauw B (1990) Cardiac Hypertrophy and Failure. John Libbey & Co. Ltd., London
Taylor M, Treisman R, Garrett N, Mohun T (1989) Muscle-specific (CArG) and serum-responsive (SRE) promoter elements are functionally interchangeable in Xenopus embryos and mouse fibroblasts. Development 106:67–78
Taylor MV (1991) A family of muscle gene promoter element (CArG) binding activities in Xenopus embryos: CArG/SRE discrimination and distribution during myogenesis. Nucleic Acids Res 19:2669–2675
Treisman R (1986) Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46:567–574
Tuil D, Clergue N, Montarras D, Pinset C, Kahn A, Phan-Dinh-Tuy F (1990) CC Ar GG boxes, cis-acting elements with a dual specificity: Muscle-specific transcriptional activation and serum responsiveness. J Mol Biol 213:677–686
Walsh K (1989) Cross-binding of factors to functionally different promoter elements in c-fos and skeletal actin genes. Mol Cell Biol 9:2191–2201
Weintraub H, Davis R, Tapscott S, Thayer M, Krause M, Benezra R, Blackwell TK, Turner D, Rupp R, Hollenberg S, Zhuang Y, Lassar A (1991) The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251:761–766
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt
About this paper
Cite this paper
Schneider, M.D., McLellan, W.R., Black, F.M., Parker, T.G. (1992). Growth factors, growth factor response elements, and the cardiac phenotype. In: Holtz, J., Drexler, H., Just, H. (eds) Cardiac Adaptation in Heart Failure. Steinkopff. https://doi.org/10.1007/978-3-642-72477-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-72477-0_4
Publisher Name: Steinkopff
Print ISBN: 978-3-642-72479-4
Online ISBN: 978-3-642-72477-0
eBook Packages: Springer Book Archive